Approval of Capital Reduction (Free Reduction) to Cover Deficits - 25.8% Attendance, 93.3% Approval
-
Proposal for capital reduction (free reduction) to cover deficits was approved at the extraordinary general meeting
-
Attendance 25.8% of total voting shares, approval rate 93.3%, opposition/abstention 6.7%
-
The free reduction reduces number of shares without compensation to shareholders, aiming to improve financial structure
KOSDAQ Filing Information
-
Filing: Result of Extraordinary General Meeting of Shareholders
-
Company: Telcon RF Pharmaceutical (200230)
-
Submission: Telcon RF Pharmaceutical. Inc.
-
Receipt: 05-21-2026
-
Under KRX KOSDAQ Market Division